Canada ranked near the bottom among high‑income countries with universal health care on key measures of clinical capacity in a new study from the Fraser Institute despite reporting one of the highest levels of health spending, the think‑tank said Tuesday.
Spending high, availability low
Using comparable international data for 2024, the Fraser Institute reports that Canada was the second‑highest spender as a share of the economy (after adjusting for population age) among 32 high‑income jurisdictions that provide universal health coverage. Yet on measures of physical and human resources Canada ranked near the bottom of that peer group.
| Measure | Canada's rank | Comparison group size |
|---|---|---|
| Availability of doctors | 30th | 32 countries |
| Hospital beds | 26th | 31 countries |
| MRI machines | 28th | 31 countries |
| CT scanners | 28th | 31 countries |
The study compares Canada with other high‑income nations that operate universal health systems — including the United Kingdom, Australia, the Netherlands, Sweden, Germany, Japan and others — and concludes there is a “clear imbalance” between what Canada spends and the level of care accessible to Canadians, according to the report’s co‑author.
“There’s a clear imbalance between the high cost of Canada’s health‑care system and the actual care Canadians receive,”
The Fraser Institute highlighted shorter waits and greater access in several peer jurisdictions and urged policymakers to study other countries’ approaches to delivering universal care at lower cost and with faster access.
What the numbers mean for patients and policy
The findings underscore two persistent policy challenges for Canada: how to translate high spending into timely, accessible care, and how to expand clinical capacity — physicians, inpatient beds and diagnostic equipment — to meet demand.
- High spending does not automatically ensure greater supply: Canada’s position as the second‑highest spender contrasts sharply with low rankings for physical and human resources.
- Resource shortages can affect wait times and access to diagnostics, which were highlighted as concerns in the Fraser Institute analysis.
- International comparisons are complicated by differing models of delivery, scope of services covered, and how resources are measured; the study adjusts for population age but other structural differences remain.
The Fraser Institute described itself in the release as an independent, non‑partisan public policy research organisation with offices across Canada and a global network of partner think‑tanks. The study presents international data for 2024 — the latest year of comparable information — and frames its findings as lessons for policymakers seeking both cost‑effectiveness and improved access.
Context and limitations
International rankings can drive public discussion but must be interpreted cautiously. The study compares countries with different hospital systems, workforce models and service mixes. The Fraser Institute adjusted spending for age structure, but other factors such as regional distribution of services, private sector roles, remuneration models and population health needs can influence both costs and resource counts.
Nonetheless, the study adds a quantifiable element to debates about health‑care reform by highlighting gaps between expenditure and tangible care capacity. For patients, the salient implications are around access to physicians, availability of inpatient beds and timely diagnostic imaging — all factors that affect how quickly and effectively health issues are diagnosed and treated.
Policymakers at federal and provincial levels face choices about whether to prioritise investments in workforce training and retention, capital for diagnostic and acute‑care capacity, or system redesign intended to deliver comparable outcomes with lower per‑capita spending. The Fraser Institute argues that other universal systems demonstrate that such trade‑offs can be managed in ways that produce shorter wait times and broader access.
As governments consider budget priorities and reforms, the study’s data will likely be cited by stakeholders on all sides of the health‑care debate — from those pressing for greater investment in hospitals and medical technology to advocates urging systemic change in how care is organised and paid for.
